Skip to main content
Watch Insiders
Market intelligence
NSRXSector not reported

Nasus Pharma Ltd insider activity

In the last 90 days, 1 corporate insider purchased $31,209 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
1
90-day purchase value
$31,209
Corporate buyers
1
Latest transaction
Jun 17, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 17, 2026Dan Benjamin TelemanChief Executive OfficerOpen Market Purchase6,550$3.10$20,305
Apr 22, 2026Dan Benjamin TelemanChief Executive OfficerOpen Market Purchase2,900$3.76$10,904